capture tumor evolution, biological subgroups, and prognostic heterogeneity, defining clinically relevant molecular classes of NENs. A second major theme is the shift toward clinically meaningful risk stratification. Although grade, stage, differentiation, and anatomical site remain essential prognostic factors in NENs, they do not fully capture disease complexity. The NUTRIGETNE study expands risk assessment in GEP-NENs by predicting malnutrition and sarcopenia [6], highlighting the relevance of nutritional status, muscle mass, and functional vulnerability for outcomes, treatment tolerance, quality of life, and long-term management. The same need for refined risk assessment emerges in functioning PanNETs such as insulinomas. The early prediction of malignancy using tumor size and biochemical markers addresses a clinically relevant problem: although most insulinomas behave indolently, the timely identification of aggressive potential remains challenging [7]. Combining anatomical and biochemical information may help distinguish patients who require closer surveillance and more individualized diagnostic pathways. Similarly, the recognition of bone metastases as a high-risk feature in metastatic NETs, particularly in NETs of unknown primary origin, highlights the prognostic relevance of disease distribution [8]. These studies suggest that risk stratification should increasingly integrate tumor biology, functional phenotype, disease burden, metastatic pattern, and host-related factors. The Research Topic highlights the biological and clinical determinants of NET development within specific tissue contexts. Type 1 gastric NETs associated with autoimmune atrophic gastritis exemplify the interplay between chronic inflammation, endocrine cell alterations, and the gastric microenvironment [9]. Integrating pathological context, host-related factors, and tumor biology may support individualized surveillance strategies and advance translational research. RWE is essential in rare tumors. The Italian Association for Neuroendocrine Tumors survey on pheochromocytomas and paragangliomas (PPGLs) reveals variability in diagnostic and clinical practice, highlighting the need for harmonization across centers [10]. RWE identifies gaps between guidelines, expert consensus, and daily practice, helping optimize biochemical testing, imaging, genetic assessment, multidisciplinary evaluation, and follow-up by assessing the implementation of classification and diagnostic principles in clinical settings. Collectively, this Research Topic highlights four converging directions in NEN research: biomarkerinformed classification incorporating tissue markers, receptor profiles, lineage factors, and nonconventional molecules [1][2][3]; molecular and epigenetic profiling to refine biological taxonomies [4,5]; prognostic stratification integrating grade, stage, nutritional status, biochemical phenotype, metastatic patterns, and disease-specific risk factors [6][7][8]; and translational models integrating pathology, molecular data, clinical phenotype, and RWE into reproducible, clinically applicable frameworks [9,10]. NEN complexity should be viewed as an opportunity for precision classification and individualized risk assessment. Future research should validate emerging biomarkers in large, well-annotated cohorts, integrate multi-omic data with histopathology, imaging, and clinical outcomes, develop robust predictive models, and harmonize diagnostic criteria across heterogeneous entities, supported by sustained multidisciplinary collaboration and patient-centered research networks. In conclusion, this Research Topic provides a timely synthesis of the evolving diagnostic, biological, and translational paradigms in NENs. The articles gathered here show that the future of NEN research lies in moving from fragmented descriptors toward integrated models of disease identity and risk. By combining morphology, biomarkers, molecular and epigenetic profiling, functional status, clinical phenotype, and RWE, the field can advance toward more precise classification, earlier recognition of aggressive behavior, and better-informed translational research.We sincerely thank all authors, reviewers, and the Frontiers editorial team for their valuable contributions to this Research Topic.
11 Authors
- RE
Roberta Elisa Rossi
Gastroenterology and Endoscopy Unit, IRCCS Humanitas Research Hospital, Italy
- MF
Matteo Ferraris
Gastroenterology and Endoscopy Unit, IRCCS Humanitas Research Hospital, Italy
- LP
Lorenzo Petronio
Gastroenterology and Endoscopy Unit, IRCCS Humanitas Research Hospital, Italy
- BM
Benedetta Masoni
Gastroenterology and Endoscopy Unit, IRCCS Humanitas Research Hospital, Italy
- LD
Luca Di Stefano
Gastroenterology and Endoscopy Unit, IRCCS Humanitas Research Hospital, Italy
- AF
Alexia Francesca Bertuzzi
Hematology and Oncology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) Humanitas Research Hospital, Italy
- SF
Sara Fraticelli
Department of Biomedical Sciences, Humanitas University, Italy
- AG
Andrea Gerardo Antonio Lania
Department of Biomedical Sciences, Humanitas University, Italy
- AZ
Alessandro Zerbi
Department of Biomedical Sciences, Humanitas University, Italy
- CH
Cesare Hassan
Gastroenterology and Endoscopy Unit, IRCCS Humanitas Research Hospital, Italy
- AR
Alessandro Repici
Gastroenterology and Endoscopy Unit, IRCCS Humanitas Research Hospital, Italy
2,548 views
22 Authors
- MA
Maria Argente-Pla
Joint Research Unit on Endocrinology, Nutrition and Clinical Dietetics, University of Valencia-Health Research Institute La Fe, Spain
- MA
Miguel Antonio Sampedro-Nuñez
Endocrinology and Nutrition Department, Hospital de La Princesa, Spain
- RG
Rocio Garcia-Carbonero
Medical Oncology Department, Hospital Universitario 12 de Octubre, Imas12, Facultad de Medicina, UCM, Spain
- AC
Ana Custodio
Medical Oncology Department, Hospital Universitario La Paz, Instituto de Investigación Biomédica Hospital Universitario La Paz (IdiPAZ), Spain
- JH
Jorge Hernando
Medical Oncology Department, Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Spain
- LS
Lorena Suarez
Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Spain
- LH
Lorena Hernandez-Rienda
Joint Research Unit on Endocrinology, Nutrition and Clinical Dietetics, University of Valencia-Health Research Institute La Fe, Spain
- IP
Inmaculada Peiró
Clinical Nutrition Unit, Institut Català d'Oncologia (ICO), l'Hospitalet de Llobregat, Spain
- VA
Vicente Alonso
Medical Oncology Department, Instituto Aragones de Investigacion Sanitaria, Hospital Universitario Miguel Servet, Spain
- RS
Raquel Serrano
Medical Oncology Department, Hospital Universitario Reina Sofía, Instituto Maimonides de Investigación Biomedica (IMIBIC), Spain
- NV
Nuria Valdés
Endocrinology and Nutrition Department, University Hospital Cruces, Bilbao, Biobizkaia, CIBERDEM/CIBERER, EndoERN, UPV/EHU, Spain
- MM
Marcos Melian
Medical Oncology Department, Instituto Valenciano de Oncología (IVO), Spain
- BF
Beatriz Febrero
Department of Endocrine Surgery, General Surgery Service, Virgen de la Arrixaca University Hospital, Spain
- JB
Josefina Biarnes
Endocrinology and Nutrition Department, Hospital Universitari de Girona Dr. Josep Trueta, Spain
- JÁ
José Ángel Díaz-Pérez
Endocrinology and Nutrition Department, Hospital Universitario Clínico San Carlos, Spain
- JM
Javier Molina-Cerrillo
Medical Oncology Department, Hospital Universitario Ramón y Cajal, Spain
- CL
Carlos Lopez
Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, UNICAN, Spain
- MÁ
Miguel Ángel Martínez Olmos
Endocrinology and Nutrition Department, Complejo Hospitalario Universitario de Santiago, Spain
- JF
Juan Francisco Merino-Torres
Joint Research Unit on Endocrinology, Nutrition and Clinical Dietetics, University of Valencia-Health Research Institute La Fe, Spain
- JC
Jaume Capdevila
Medical Oncology Department, Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Spain
- MD
Maribel del Olmo-García
Joint Research Unit on Endocrinology, Nutrition and Clinical Dietetics, University of Valencia-Health Research Institute La Fe, Spain
- NG
NUTRIGETNE GROUP
Joint Research Unit on Endocrinology, Nutrition and Clinical Dietetics, University of Valencia-Health Research Institute La Fe, Spain
1,608 views
5 Authors
- LL
Linzhen Li
Department of Gastroenterology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China
- HY
Hui Yin
Department of Infection Management, The First Affiliated Hospital of Wannan Medical College, Wuhu, China
- AH
Asi He
Department of Gastroenterology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China
- YY
Yayun Ye
Department of Gastroenterology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China
- YZ
Yan Zhang
Department of Gastroenterology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China
1,281 views
8 Authors
- AL
Anna La Salvia
National Center for Drug Research and Evaluation, National Institute of Health (ISS), Italy
- AT
Alessandro Tanca
Department of Biomedical Sciences, University of Sassari, Italy
- GG
Germano Gaudenzi
Laboratory of Geriatric and Oncologic Neuroendocrinology Research, IRCCS, Istituto Auxologico Italiano, Cusano Milanino, Italy
- GP
Giulia Pecora
Endocrinology Unit, Department of Clinical and Molecular Medicine, The European Neuroendocrine Tumor Society (ENETS) Center of Excellence, Sant’Andrea Hospital, Sapienza University of Rome, Italy
- AF
Antongiulio Faggiano
Endocrinology Unit, Department of Clinical and Molecular Medicine, The European Neuroendocrine Tumor Society (ENETS) Center of Excellence, Sant’Andrea Hospital, Sapienza University of Rome, Italy
- GV
Giovanni Vitale
Laboratory of Geriatric and Oncologic Neuroendocrinology Research, IRCCS, Istituto Auxologico Italiano, Cusano Milanino, Italy
- PC
Paolo Cossu-Rocca
Department of Medicine, Surgery and Pharmacy, University of Sassari, Italy
- GF
Giuseppe Fanciulli
Department of Medicine, Surgery and Pharmacy, University of Sassari - University Hospital (AOU) of Sassari, Italy
832 views
30 Authors
- MK
Maciej Kolodziej
Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Poland
- MO
Marta Opalinska
Chair and Department of Endocrinology, Jagiellonian University Medical College, Poland
- RM
Renata Mikolajczak
Radioisotope Centre POLATOM, National Centre for Nuclear Research, Poland
- AH
Alicja Hubalewska-Dydejczyk
Chair and Department of Endocrinology, Jagiellonian University Medical College, Poland
- MD
Marek Dedecjus
Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Poland
- AK
Aldona Kowalska
Collegium Medicum, Jan Kochanowski University, Poland
- MS
Marek Saracyn
Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Poland
- PG
Piotr Garnuszek
Radioisotope Centre POLATOM, National Centre for Nuclear Research, Poland
- IC
Izabela Cieszykowska
Radioisotope Centre POLATOM, National Centre for Nuclear Research, Poland
- JJ
Joanna Januszkiewicz-Caulier
Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Poland
- JD
Joanna Dlugosinska
Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Poland
- AD
Adam Daniel Durma
Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Poland
- KJ
Katarzyna Jozwik-Plebanek
Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Poland
- AM
Adrianna Mroz
Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Poland
- KJ
Katarzyna Janiak
Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Poland
- DG
Danuta Gasior-Perczak
Collegium Medicum, Jan Kochanowski University, Poland
- MT
Malgorzata Trofimiuk-Muldner
Chair and Department of Endocrinology, Jagiellonian University Medical College, Poland
- AS
Anna Sowa-Staszczak
Chair and Department of Endocrinology, Jagiellonian University Medical College, Poland
- JB
Janusz Braziewicz
Department of Nuclear Medicine, Holy Cross Cancer Center, Poland
- WL
Wioletta Lenda-Tracz
Faculty of Health Sciences, Jagiellonian University Medical College, Poland
- KK
Krzysztof Kacperski
Particle Acceleration Physics and Technology Division, National Centre for Nuclear Research, Poland
- AB
Anna Budzynska
Department of Nuclear Medicine, Military Institute of Medicine - National Research Institute, Poland
- AK
Agata Kubik
Department of Nuclear Medicine, Military Institute of Medicine - National Research Institute, Poland
- PP
Patrycja Pastusiak
Department of Nuclear Medicine, Military Institute of Medicine - National Research Institute, Poland
- WC
Wioletta Chalewska
Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Poland
- AB
Anna Borkowska
Faculty of Health Sciences, Jagiellonian University Medical College, Poland
- PC
Paulina Cegla
Department of Endocrine Oncology and Nuclear Medicine, National Institute of Oncology - National Research Institute, Poland
- AW
Agata Walecka-Mazur
Department of Endocrinology, Holy Cross Cancer Center, Poland
- AS
Artur Szczodry
Department of Endocrinology, Holy Cross Cancer Center, Poland
- GK
Grzegorz Kaminski
Department of Endocrinology and Isotope Therapy, Military Institute of Medicine - National Research Institute, Poland
9 Authors
- AP
Antonio Prinzi
Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Medical Center, Italy
- GF
Ginevra Fava
Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Medical Center, Italy
- IB
Ignazio Bacchi
Unit of Endocrinology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Policlinico Paolo Giaccone, Università Degli Studi di Palermo, Italy
- FS
Federica Spitali
Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Medical Center, Italy
- AG
Antonio Galvano
Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), University of Palermo, Italy
- GA
Giorgio Arnaldi
Unit of Endocrinology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Policlinico Paolo Giaccone, Università Degli Studi di Palermo, Italy
- FF
Francesco Frasca
Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Medical Center, Italy
- VG
Valentina Guarnotta
Unit of Endocrinology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Policlinico Paolo Giaccone, Università Degli Studi di Palermo, Italy
- PM
Pasqualino Malandrino
Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Medical Center, Italy



